Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Sysmex Corporation (Sysmex), a in vitro diagnostics company and Siemens Healthcare, a germany-based medical devices company, announced the signing of a five-year contract renewal for a global supply, distributorship, sales and service agreement. Under the agreement, clinical laboratory customers around the world continue to have access to the portfolio of coagulation instruments and tests.
Subscribe to our email newsletter
The companies will also continue joint product development activities ensuring customers have continued access to new coagulation technology.
“Our shared value to deliver quality products and services that address our customers’ needs is a key contributor to the success of our 14-year partnership,” said Donal Quinn, chief executive officer (CEO), Siemens Healthcare Diagnostics. “Together, we expect to not only offer customers the broad portfolio of coagulation products they have come to expect from us today, but also to deliver next-generation technology in the future.”
“We are pleased to continue our long-standing relationship with Siemens Healthcare,” said Hisashi Ietsugu, president & CEO, Sysmex. “Our partnership combines the strengths of two leading diagnostic companies whose joint expertise offers best-in-class solutions for the laboratory, and we look forward to expanding the clinical utility of these solutions cooperatively.”